Shimerda v. Nebraska Serum Co.

169 N.W. 785, 102 Neb. 812, 1918 Neb. LEXIS 164
CourtNebraska Supreme Court
DecidedNovember 30, 1918
DocketNo. 20168
StatusPublished
Cited by1 cases

This text of 169 N.W. 785 (Shimerda v. Nebraska Serum Co.) is published on Counsel Stack Legal Research, covering Nebraska Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Shimerda v. Nebraska Serum Co., 169 N.W. 785, 102 Neb. 812, 1918 Neb. LEXIS 164 (Neb. 1918).

Opinions

Aldrich, J.

This is an action at law, where one John Shimerda, of Saline county, sues the Nebraska Serum Company to recover damages growing out of administering hog cholera serum, sold by the defendant, when the same was alleged to have been spoiled and poisonous. By administering said medicine, it is alleged to have caused his hogs to the number of 202 to sicken and die.

The evidence in support of the allegations in the petition.herein was submitted to a jury, which found- a verdict for plaintiff in the sum of $1,375. The issues in this case are comparatively simple. The sole question, as we view it, is: Was the verdict of the jury sustained by sufficient evidence? There is no controverted question of law here giving grounds for controversy.

This case is decided in accordance- with the well-known and recognized rule of this court, to wit, the finding of a jury based- on conflicting evidence will not be disturbed unless it is clearly wrong.

[813]*813Defendant claims this verdict, if sustained, will work great injury to it in its manufacture of hog cholera serum. We answer that, if the serum .manufacturers will take certain simple precautions, it will enable them to make, at least, a defense to actions of this kind. For instance, defendant in the case at bar could have met the contentions of plaintiff, had it simply shown that the serum was aseptically prepared, and could have further shown that there was no poisonous or deleterious ingredients in the serum at the time of its manufacture, sale and delivery.

Then, further, when parting with said medicine, a record or examination might have disclosed that certain tests had been made for the purpose of ascertaining whether any foreign substances were in the same, and that said medicine was not in a septic condition at the time of delivery.

Evidence shows that said medicine was administered in a clean, sanitary and scientific manner.

Affirmed.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Brown v. Globe Laboratories, Inc.
84 N.W.2d 151 (Nebraska Supreme Court, 1957)

Cite This Page — Counsel Stack

Bluebook (online)
169 N.W. 785, 102 Neb. 812, 1918 Neb. LEXIS 164, Counsel Stack Legal Research, https://law.counselstack.com/opinion/shimerda-v-nebraska-serum-co-neb-1918.